Pan Dan, Qu Yilun, Shi Chunru, Xu Cheng, Zhang Jie, Du Hongjian, Chen Xiangmei
The College of Traditional Chinese Medicine, Guangdong Pharmaceutical University, Guangzhou, 510006, China.
Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Kidney Diseases Research, Beijing, 100853, China.
Chin Med. 2024 May 30;19(1):74. doi: 10.1186/s13020-024-00934-w.
Kidney diseases pose a significant threat to human health due to their high prevalence and mortality rates. Worryingly, the clinical use of drugs for kidney diseases is associated with more side effects, so more effective and safer treatments are urgently needed. Oleanolic acid (OA) is a common pentacyclic triterpenoid that is widely available in nature and has been shown to have protective effects in kidney disease. However, comprehensive studies on its role in kidney diseases are still lacking. Therefore, this article first explores the botanical sources, pharmacokinetics, derivatives, and safety of OA, followed by a summary of the anti-inflammatory, immunomodulatory, anti-oxidative stress, autophagy-enhancing, and antifibrotic effects of OA and its analogues in renal diseases, and an analysis of the molecular mechanisms, aiming to provide further insights for the development of novel drugs for the treatment of kidney diseases.
肾脏疾病因其高患病率和死亡率对人类健康构成重大威胁。令人担忧的是,用于治疗肾脏疾病的药物在临床应用中会产生更多副作用,因此迫切需要更有效、更安全的治疗方法。齐墩果酸(OA)是一种常见的五环三萜类化合物,在自然界中广泛存在,并且已被证明在肾脏疾病中具有保护作用。然而,关于其在肾脏疾病中作用的全面研究仍然缺乏。因此,本文首先探讨OA的植物来源、药代动力学、衍生物和安全性,随后总结OA及其类似物在肾脏疾病中的抗炎、免疫调节、抗氧化应激、增强自噬和抗纤维化作用,并分析其分子机制,旨在为开发治疗肾脏疾病的新型药物提供进一步的见解。